U. Vogl

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.

R. Cathomas, C. Buttigliero, M. Tucci, 2023, Prostate cancer and prostatic diseases.

Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.

Massimiliano Cani, R. Pereira Mestre, F. Turco, 2024, European Urology Oncology.

Hormonal agents in localized and advanced prostate cancer: current use and future perspectives.

N. Fossati, A. Gallina, C. Buttigliero, 2024, Clinical Genitourinary Cancer.

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer

C. Buttigliero, M. Tucci, S. Poletto, 2023, International journal of molecular sciences.

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

N. Tunariu, A. Stathis, R. Ruddle, 2023, Nature.

Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review

B. De Bari, M. Müntener, A. Papachristofilou, 2024, World journal of urology.